Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 016380.KS
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 3.50 1.97 1.90
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -22.11 14.06 18.05
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -0.84 18733.41 18891.62
Cash 9.23 3468.46 3175.48
Capex -54.60 -185.49 -119.98
Free Cash Flow -83.91 88.09 547.37
Revenue -2.35 8180.90 8377.71
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 15.71 0.10 0.08
Operating Margin 57.36 0.06 0.04
ROA -93.76 < 0.005 0.02
ROE -93.90 < 0.005 0.04
ROIC -23.33 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 016380.KS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 016380.KS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 016380.KS is permitted for members.